patients’ groups
Majority of US patients’ groups supporting pharma against Medicare reforms received industry funding, claims report
August 5, 2016Medical Communications, Research and Development medicare reform, patients' groups, public citizen
An overwhelming majority of US patients’ groups who supported the pharmaceutical industry in opposing Medicare part B pricing reforms receive …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
